Published in Mucosal Immunol on July 27, 2016
The Role of the Microbiota in Shaping Infectious Immunity. Trends Immunol (2016) 0.76
Emerging Trends in "Smart Probiotics": Functional Consideration for the Development of Novel Health and Industrial Applications. Front Microbiol (2017) 0.75
Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med (2013) 20.65
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A (2008) 14.18
Diet rapidly and reproducibly alters the human gut microbiome. Nature (2013) 11.04
Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut (2005) 10.95
NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell (2011) 9.75
Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell (2006) 9.64
Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell (2007) 8.42
Genetics and pathogenesis of inflammatory bowel disease. Nature (2011) 7.79
The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe (2014) 7.43
Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology (2012) 6.04
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol (2012) 5.66
Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis (2009) 4.72
Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol (2013) 4.46
Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis (2011) 4.09
Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature (2014) 4.00
Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol (2012) 3.84
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology (2015) 3.84
Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA (2014) 3.66
Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science (2013) 3.54
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis. Gastroenterology (2015) 3.12
Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol (2013) 2.85
Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr (2013) 2.57
Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children. Aliment Pharmacol Ther (2014) 2.37
Dynamics and associations of microbial community types across the human body. Nature (2014) 2.32
Molecular inventory of faecal microflora in patients with Crohn's disease. FEMS Microbiol Ecol (2004) 2.21
Fecal microbial transplant via nasogastric tube for active pediatric ulcerative colitis. J Pediatr Gastroenterol Nutr (2015) 2.10
Weight gain after fecal microbiota transplantation. Open Forum Infect Dis (2015) 2.05
Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis (2014) 1.96
Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science (2016) 1.87
Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut (2015) 1.76
Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease. Inflamm Bowel Dis (2015) 1.74
Storage conditions of intestinal microbiota matter in metagenomic analysis. BMC Microbiol (2012) 1.64
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. Gastroenterology (2015) 1.42
Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol (2013) 1.38
Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol (2015) 1.33
The intestinal microbiota in inflammatory bowel diseases: time to connect with the host. Curr Opin Gastroenterol (2010) 1.22
Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease. J Crohns Colitis (2015) 1.15
Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. Clin Gastroenterol Hepatol (2016) 1.13
Variable alterations of the microbiota, without metabolic or immunological change, following faecal microbiota transplantation in patients with chronic pouchitis. Sci Rep (2015) 1.03
Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii. MBio (2015) 1.00
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes (2016) 0.99
Clostridium difficile Infection. N Engl J Med (2015) 0.97
Successful treatment of chronic Pouchitis utilizing fecal microbiota transplantation (FMT): a case report. Int J Colorectal Dis (2015) 0.94
Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis. J Transl Med (2015) 0.94
Fatal Aspiration Pneumonia as a Complication of Fecal Microbiota Transplant. Clin Infect Dis (2015) 0.88
Optimal screening and donor management in a public stool bank. Microbiome (2015) 0.88
Fecal Microbiota Transplantation for Ulcerative Colitis: Not Just Yet. Gastroenterology (2015) 0.84
Fecal microbiota transplantation: in perspective. Therap Adv Gastroenterol (2016) 0.82
Toward Rational Donor Selection in Faecal Microbiota Transplantation for IBD. J Crohns Colitis (2016) 0.76